Not a bad read overall but yes very contingent on the authorities, I liked how ALL of the MPS patients in Brazil opt for further treatment, that's a good sign that the like the drug and are deriving benefit from it.
"Following the conclusion of Paradigm’s successful multi-centre phase 2 clinical trial,
randomising 13 MPS VI participants to iPPS or placebo, all 13 participants have elected to
continue or commence (for the placebo group) ongoing iPPS treatment".
Not a bad read overall but yes very contingent on the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.035(7.53%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.5¢ | 42.0¢ | $676.1K | 1.519M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16161 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 19584 | 1 |
View Market Depth
| Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |